TrialAddiction (Abingdon, England)2026

Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial.

Francesco Versace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.